THE CEO
LETTER
GRI Index
- Strategy and Analysis
GRI Guideline Corresponding Pfizer Material UNGC Principle 1.1 Statement from the most senior decision-maker of the organization (e.g., CEO, chair, or equivalent senior position) about the relevance of sustainability to the organization and its strategy. From Our CEO 1.2 Description of key impacts, risks, and opportunities. From Our CEO
Ethics
Research and Development
Environment Health and Safety8 
Covered
Partially Covered
Not Covered
- Organizational Profile
GRI Guideline Corresponding Pfizer Material UNGC Principle 2.1 Name of the organization. Corporate Overview 2.2 Primary brands, products, and/or services. Pfizer Products 2.3 Operational structure of the organization, including main divisions, operating companies, subsidiaries, and joint ventures. How We Are Organized 2.4 Location of organization's headquarters. Contact 2.5 Number of countries where the organization operates, and names of countries with either major operations or that are specifically relevant to the sustainability issues covered in the report. 2.6 Nature of ownership and legal form. 2.7 Markets served (including geographic breakdown, sectors served, and types of customers/beneficiaries). Global Opportunities 2.8 Scale of the reporting organization About This Review 2.9 Significant changes during the reporting period regarding size, structure, or ownership 2.10 Awards received in the reporting period. Accolades
Covered
Partially Covered
Not Covered
- Report Parameters
Report Profile
GRI Guideline Corresponding Pfizer Material UNGC Principle 3.1 Reporting period (e.g., fiscal/calendar year) for information provided. About This Review 3.2 Date of most recent previous report (if any). 3.3 Reporting cycle (annual, biennial, etc.) About This Review 3.4 Contact point for questions regarding the report or its contents. Report Scope and Boundary
GRI Guideline Corresponding Pfizer Material UNGC Principle 3.5 Process for defining report content. About This Review 3.6 Boundary of the report (e.g., countries, divisions, subsidiaries, leased facilities, joint ventures, suppliers). See GRI Boundary Protocol for further guidance. About This Review 3.7 State any specific limitations on the scope or boundary of the report. N/A 3.8 Basis for reporting on joint ventures, subsidiaries, leased facilities, outsourced operations, and other entities that can significantly affect comparability from period to period and/or between organizations. 3.9 Data measurement techniques and the bases of calculations, including assumptions and techniques underlying estimations applied to the compilation of the Indicators and other information in the report. 3.10 Explanation of the effect of any re-statements of information provided in earlier reports, and the reasons for such re-statement (e.g., mergers/acquisitions, change of base years/periods, nature of business, measurement methods). N/A 3.11 Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report. N/A GRI Content Index
GRI Guideline Corresponding Pfizer Material UNGC Principle 3.12 Table identifying the location of the Standard Disclosures in the report. GRI Index Assurance
GRI Guideline Corresponding Pfizer Material UNGC Principle 3.13 Policy and current practice with regard to seeking external assurance for the report. If not included in the assurance report accompanying the sustainability report, explain the scope and basis of any external assurance provided. Also explain the relationship between the reporting organization and the assurance provider(s).
Covered
Partially Covered
Not Covered
- Governance, Commitments,
and Engagement
GOVERNANCE
GRI Guideline Corresponding Pfizer Material UNGC Principle 4.1 Governance structure of the organization, including committees under the highest governance body responsible for specific tasks, such as setting strategy or organizational oversight. Governance
Corporate Governance4.2 Indicate whether the Chair of the highest governance body is also an executive officer (and, if so, their function within the organization's management and the reasons for this arrangement). Governance
Corporate Governance4.3 For organizations that have a unitary board structure, state the number of members of the highest governance body that are independent and/or non-executive members. Fact Sheet 4.4 Mechanisms for shareholders and employees to provide recommendations or direction to the highest governance body. 4.5 Linkage between compensation for members of the highest governance body, senior managers, and executives (including departure arrangements), and the organization's performance (including social and environmental performance). Governance
Charter Compensation Committee4.6 Processes in place for the highest governance body to ensure conflicts of interest are avoided. Corporate Governance 4.7 Process for determining the qualifications and expertise of the members of the highest governance body for guiding the organization's strategy on economic, environmental, and social topics. Governance
Corporate Governance4.8 Internally developed statements of mission or values, codes of conduct, and principles relevant to economic, environmental, and social performance and the status of their implementation. Governance
Ethics4.9 Procedures of the highest governance body for overseeing the organization's identification and management of economic, environmental, and social performance, including relevant risks and opportunities, and adherence or compliance with internationally agreed standards, codes of conduct, and principles. 4.10 Processes for evaluating the highest governance body's own performance, particularly with respect to economic, environmental, and social performance. COMMITMENTS TO EXTERNAL INITIATIVES
GRI Guideline Corresponding Pfizer Material UNGC Principle 4.11 Explanation of whether and how the precautionary approach or principle is addressed by the organization. Ethics 7 4.12 Externally developed economic, environmental, and social charters, principles, or other initiatives to which the organization subscribes or endorses. Clinical Trials
Sales and Marketing
Access
Manufacturing and Supply Chain4.13 Memberships in associations (such as industry associations) and/or national/international advocacy organizations in which the organization: - has positions in governance bodies; - participates in projects or committees; - provides substantive funding beyond routine membership dues; - views membership as strategic. STAKEHOLDER ENGAGEMENT
GRI Guideline Corresponding Pfizer Material UNGC Principle 4.14 List of stakeholder groups engaged by the organization. 4.15 Basis for identification and selection of stakeholders with whom to engage. Stakeholder Engagement 4.16 Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group. Stakeholder Engagement 4.17 Key topics and concerns that have been raised through stakeholder engagement, and how the organization has responded to those key topics and concerns, including through its reporting.
Covered
Partially Covered
Not Covered
- Management
Approach and Performance Indicators
ECONOMIC DISCLOSURES
The economic dimension of sustainability concerns the organization's impacts on the economic conditions of its stakeholders and on economic systems at local, national, and global levels. The Economic Indicators illustrate:
- Flow of capital among different stakeholders; and
- Main economic impacts of the organization throughout society.
- Disclosure on Management Approach (Economy)
Provide a concise disclosure on the Management Approach items outlined below with reference to the following Economic Aspects:
- Economic Performance;
- Market Presence; and
- Indirect Economic Impacts.
GRI Guideline Corresponding Pfizer Material UNGC Principle GOALS AND PERFORMANCE
Organization-wide goals regarding performance relevant to the Economic Aspects.
Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.From Our CEO
Humanity
InnovationPOLICY
Brief, organization-wide policy (or policies) that defines the organization's overall commitment relating to the Economic Aspects listed above, or state where this can be found in the public domain (e.g., web link).From Our CEO
Global Opportunities
Expanding Access to HealthADDITIONAL CONTEXTUAL INFORMATION
Additional relevant information required to understand organizational performance, such as:
- Key successes and shortcomings;
- Major organizational risks and opportunities;
- Major changes in the reporting period to systems or structures to improve performance; and
- Key strategies for implementing policies or achieving performance.
From Our CEO
Global Opportunities
Expanding Access to Health
Covered
Partially Covered
Not Covered
- Economic Performance Indicators
ASPECT: ECONOMIC PERFORMANCE
GRI Guideline Corresponding Pfizer Material UNGC Principle EC1 Direct economic value generated and distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments. Financial Performance EC2 Financial implications and other risks and opportunities for the organization's activities due to climate change. Humanity 7, 8 EC3 Coverage of the organization's defined benefit plan obligations. EC4 Significant financial assistance received from government. ASPECT: MARKET PRESENCE
GRI Guideline Corresponding Pfizer Material UNGC Principle EC5 Range of ratios of standard entry level wage compared to local minimum wage at significant locations of operation. 6 EC6 Policy, practices, and proportion of spending on locally-based suppliers at significant locations of operation. EC7 Procedures for local hiring and proportion of senior management hired from the local community at locations of significant operation. 6 ASPECT: INDIRECT ECONOMIC IMPACTS
GRI Guideline Corresponding Pfizer Material UNGC Principle EC8 Development and impact of infrastructure investments and services provided primarily for public benefit through commercial, in-kind, or pro bono engagement. Investments in Health EC9 Understanding and describing significant indirect economic impacts, including the extent of impacts. Investments in Health
Covered
Partially Covered
Not Covered
ENVIRONMENTAL DISCLOSURES
The environmental dimension of sustainability concerns an organization's impacts on living and non-living natural systems, including ecosystems, land, air, and water. Environmental Indicators cover performance related to inputs (e.g., material, energy, water) and outputs (e.g., emissions, effluents, waste). In addition, they cover performance related to biodiversity, environmental compliance, and other relevant information such as environmental expenditure and the impacts of products and services.
- Disclosure on Management Approach (Environment)
Provide a concise disclosure on the Management Approach items outlined below with reference to the following Environmental Aspects:
- Materials;
- Energy;
- Water;
- Biodiversity;
- Emissions, Effluents, and Waste;
- Products and Services;
- Compliance;
- Transport; and
- Overall
GRI Guideline Corresponding Pfizer Material UNGC Principle GOALS AND PERFORMANCE
Organization-wide goals regarding performance relevant to the Environmental Aspects.
Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.Environment—Priorities and Strategies POLICY
Brief, organization-wide policy (or policies) that defines the organization's overall commitment related to the Environmental Aspects listed above or state where this can be found in the public domain (e.g., web link).Environment—Climate Change ORGANIZATIONAL RESPONSIBILITY
The most senior position with operational responsibility for Environmental Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.Environment—EHS Governance TRAINING AND AWARENESS
Procedures related to training and raising awareness in relation to the Environmental Aspects.Coaching and Training MONITORING AND FOLLOW-UP
Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain.
List of certifications for environment-related performance or certification systems, or other approaches to auditing/verification for the reporting organization or its supply chain.Assessment and Improvement ADDITIONAL CONTEXTUAL INFORMATION
Additional relevant information required to understand organizational performance, such as:
- Key successes and shortcomings;
- Major organizational risks and opportunities;
- Major changes in the reporting period to systems or structures to improve performance; and
- Key strategies and procedures for implementing policies or achieving goals.
Protecting the Environment
Covered
Partially Covered
Not Covered
- Environmental Performance Indicators
ASPECT: MATERIALS
GRI Guideline Corresponding Pfizer Material UNGC Principle EN1 Materials used by weight or volume. 8 EN2 Percentage of materials used that are recycled input materials. 8, 9
ASPECT: ENERGY
GRI Guideline Corresponding Pfizer Material UNGC Principle EN3 Direct energy consumption by primary energy source. 8 EN4 Indirect energy consumption by primary source. 8 EN5 Energy saved due to conservation and efficiency improvements. 8, 9 EN6 Initiatives to provide energy-efficient or renewable energy based products and services, and reductions in energy requirements as a result of these initiatives. Environment—KPI Dashboard 8, 9 EN7 Initiatives to reduce indirect energy consumption and reductions achieved. Environment—KPI Dashboard 8, 9
ASPECT: WATER
GRI Guideline Corresponding Pfizer Material UNGC Principle EN8 Total water withdrawal by source. Environment—KPI Dashboard 8 EN9 Water sources significantly affected by withdrawal of water. EN10 Percentage and total volume of water recycled and reused. 8
ASPECT: BIODIVERSITY
GRI Guideline Corresponding Pfizer Material UNGC Principle EN11 Location and size of land owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas. 8 EN12 Description of significant impacts of activities, products, and services on biodiversity in protected areas and areas of high biodiversity value outside protected areas. 8 EN13 Habitats protected or restored. 8 EN14 Strategies, current actions, and future plans for managing impacts on biodiversity. 8 EN15 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction risk. 8
ASPECT: EMISSIONS, EFFLUENTS, AND WASTE
GRI Guideline Corresponding Pfizer Material UNGC Principle EN16 Total direct and indirect greenhouse gas emissions by weight. Performance Highlights 8 EN17 Other relevant indirect greenhouse gas emissions by weight. Environment—KPI Dashboard 8 EN18 Initiatives to reduce greenhouse gas emissions and reductions achieved. Environment—KPI Dashboard 8, 9 EN19 Emissions of ozone-depleting substances by weight. 8 EN20 NO, SO, and other significant air emissions by type and weight. 8 EN21 Total water discharge by quality and destination. EN22 Total weight of waste by type and disposal method. 8 EN23 Total number and volume of significant spills. 8 EN24 Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally. 8 EN25 Identity, size, protected status, and biodiversity value of water bodies and related habitats significantly affected by the reporting organization's discharges of water and runoff. 8
ASPECT: PRODUCTS AND SERVICES
GRI Guideline Corresponding Pfizer Material UNGC Principle EN26 Initiatives to mitigate environmental impacts of products and services, and extent of impact mitigation. Environment—Pfizer's Green Journey 8, 9 EN27 Percentage of products sold and their packaging materials that are reclaimed by category. 8, 9
ASPECT: COMPLIANCE
GRI Guideline Corresponding Pfizer Material UNGC Principle EN28 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations. Environment—KPI Dashboard 8
ASPECT: TRANSPORT
GRI Guideline Corresponding Pfizer Material UNGC Principle EN29 Significant environmental impacts of transporting products and other goods and materials used for the organization's operations, and transporting members of the workforce. 8
ASPECT: OVERALL
GRI Guideline Corresponding Pfizer Material UNGC Principle EN30 Total environmental protection expenditures and investments by type. 8
Covered
Partially Covered
Not Covered
SOCIAL DISCLOSURES
The social dimension of sustainability concerns the impacts an organization has on the social systems within which it operates. The GRI Social Performance Indicators identify key Performance Aspects surrounding labor practices, human rights, society, and product responsibility.
- Labor Practices and Decent Work
The specific Aspects under the category of Labor Practices are based on internationally recognized universal standards, including:
- United Nations Universal Declaration of Human Rights and its Protocols;
- United Nations Convention: International Covenant on Civil and Political Rights;
- United Nations Convention: International Covenant on Economic, Social, and Cultural Rights;
- ILO Declaration on Fundamental Principles and Rights at Work of 1998 (in particular the eight core conventions of the ILO); and
- The Vienna Declaration and Programme of Action.
- Disclosure on Management Approach (Labor Practices
and Decent Work)
Provide a concise disclosure on the following Management Approach items with reference to the Labor Aspects listed below. The ILO Tripartite Declaration Concerning Multinational Enterprises and Social Policy (in particular the eight core conventions of the ILO) and the Organisation for Economic Co-operation and Development Guidelines for Multinational Enterprises, should be the primary reference points.
- Employment;
- Labor/Management Relations;
- Occupational Health and Safety;
- Training and Education; and
- Diversity and Equal Opportunity.
GRI Guideline Corresponding Pfizer Material UNGC Principle GOALS AND PERFORMANCE
Organization-wide goals regarding performance relevant to the Labor Aspects, indicating their linkage to the internationally recognized universal standards. Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.Colleagues POLICY
Brief, organization-wide policy (or policies) that defines the organization's overall commitment related to the Labor Aspects, or state where this can be found in the public domain (e.g., web link). Also reference their linkage to the international standards indicated above.Human Rights
ColleaguesORGANIZATIONAL RESPONSIBILITY
The most senior position with operational responsibility for Labor Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.TRAINING AND AWARENESS
Procedures related to training and raising awareness in relation to the Labor Aspects.MONITORING AND FOLLOW-UP
Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain.
List of certifications for labor-related performance or certification systems, or other approaches to auditing/verifying the reporting organization or its supply chain.Colleagues
PSCI and External Certifications
EHS External Supply: Commitments and Actions
ComplianceADDITIONAL CONTEXTUAL INFORMATION
Additional relevant information required to understand organizational performance, such as:
- Key successes and shortcomings;
- Major organizational environmental risks and opportunities related to issues;
- Major changes in the reporting period to systems or structures to improve performance; and
- Key strategies and procedures for implementing policies or achieving goals
Human Rights
Colleagues
Covered
Partially Covered
Not Covered
- Labor Practices and Decent Work Performance Indicators
ASPECT: EMPLOYMENT
GRI Guideline Corresponding Pfizer Material UNGC Principle LA1 Total workforce by employment type, employment contract, and region. LA2 Total number and rate of employee turnover by age group, gender, and region. 6 LA3 Benefits provided to full-time employees that are not provided to temporary or part-time employees, by major operations. 6
ASPECT: LABOR/MANAGEMENT RELATIONS
GRI Guideline Corresponding Pfizer Material UNGC Principle LA4 Percentage of employees covered by collective bargaining agreements. 1, 3 LA5 Minimum notice period(s) regarding operational changes, including whether it is specified in collective agreements. 3
ASPECT: OCCUPATIONAL HEALTH AND SAFETY
GRI Guideline Corresponding Pfizer Material UNGC Principle LA6 Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs. LA7 Rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities by region. LA8 Education, training, counseling, prevention, and risk-control programs in place to assist workforce members, their families, or community members regarding serious diseases. LA9 Health and safety topics covered in formal agreements with trade unions.
ASPECT: TRAINING AND EDUCATION
GRI Guideline Corresponding Pfizer Material UNGC Principle LA10 Average hours of training per year per employee by employee category. LA11 Programs for skills management and lifelong learning that support the continued employability of employees and assist them in managing career endings. LA12 Percentage of employees receiving regular performance and career development reviews.
ASPECT: DIVERSITY AND EQUAL OPPORTUNITY
GRI Guideline Corresponding Pfizer Material UNGC Principle LA13 Composition of governance bodies and breakdown of employees per category according to gender, age group, minority group membership, and other indicators of diversity. 1, 6 LA14 Ratio of basic salary of men to women by employee category. 1, 6
Covered
Partially Covered
Not Covered
-
Human RightsHuman Rights Performance Indicators require organizations to report on the extent to which human rights are considered in investment and supplier/contractor selection practices. Additionally, the Indicators cover employee and security forces training on human rights as well as non-discrimination, freedom of association, child labor, indigenous rights, and forced and compulsory labor.
Generally recognized human rights are defined by the following Conventions and Declarations:
- United Nations Universal Declaration of Human Rights and its Protocols;
- United Nations Convention: International Covenant on Civil and Political Rights;
- United Nations Convention: International Covenant on Economic, Social, and Cultural Rights;
- ILO Declaration on Fundamental Principles and Rights at Work of 1998 (in particular the eight core conventions of the ILO); and
- The Vienna Declaration and Programme of Action.
- Disclosure on Management Approach (Human Rights)
Provide a concise disclosure on the following Management Approach items with reference to the Human Rights Aspects listed below. The ILO Tripartite Declaration Concerning Multinational Enterprises and Social Policy (in particular the eight core conventions of the ILO which consist of Conventions 100, 111, 87, 98, 138, 182, 20 and 1059), and the Organisation for Economic Cooperation and Development Guidelines for Multinational Enterprises should be the primary reference points.
- Investment and Procurement Practices;
- Non-discrimination;
- Freedom of Association and Collective Bargaining;
- Abolition of Child Labor;
- Prevention of Forced and Compulsory Labor;
- Complaints and Grievance Practices;
- Security Practices; and
- Indigenous Rights.
GRI Guideline Corresponding Pfizer Material UNGC Principle GOALS AND PERFORMANCE
Organization-wide goals regarding performance relevant to the Human Rights Aspects, indicating their linkage to the international declarations and standards listed above.
Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.Human Rights POLICY
Brief, organization-wide policy (or policies) that defines the organization's overall commitment to the Human Rights Aspects (including policies which may be reasonably considered likely to affect the decision of employees to join a trade union or bargain collectively), or state where this can be found in the public domain (e.g., web link). Also reference their linkage to the international declarations and standards indicated above.Human Rights ORGANIZATIONAL RESPONSIBILITY
The most senior position with operational responsibility for Human Rights Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.TRAINING AND AWARENESS
Procedures related to training and raising awareness in relation to the Human Rights Aspects.MONITORING AND FOLLOW-UP
Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain.
List of certifications for human rights-related performance, or certification systems, or other approaches to auditing/verifying the reporting organization or its supply chain.Colleagues
PSCI and External Certifications
EHS External Supply: Commitments and Actions
ComplianceADDITIONAL CONTEXTUAL INFORMATION
Additional relevant information required to understand organizational performance, such as:
- Key successes and shortcomings;
- Major organizational risks and opportunities;
- Major changes in the reporting period to systems or structures to improve performance; and
- Key strategies and procedures for implementing policies or achieving goals.
Human Rights
Covered
Partially Covered
Not Covered
- Human Rights Performance Indicators
ASPECT: INVESTMENT AND PROCUREMENT PRACTICES
GRI Guideline Corresponding Pfizer Material UNGC Principle HR1 Percentage and total number of significant investment agreements that include human rights clauses or that have undergone human rights screening. 1, 2, 3, 4, 5, 6 HR2 Percentage of significant suppliers and contractors that have undergone screening on human rights and actions taken. 1, 2, 3, 4, 5, 6 HR3 Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant to operations, including the percentage of employees trained. 1, 4, 5, 6
ASPECT: NON-DISCRIMINATION
GRI Guideline Corresponding Pfizer Material UNGC Principle HR4 Total number of incidents of discrimination and actions taken. 1, 6
ASPECT: FREEDOM OF ASSOCIATION AND COLLECTIVE BARGAINING
GRI Guideline Corresponding Pfizer Material UNGC Principle HR5 Operations identified in which the right to exercise freedom of association and collective bargaining may be at significant risk, and actions taken to support these rights. 1, 3
ASPECT: CHILD LABOR
GRI Guideline Corresponding Pfizer Material UNGC Principle HR6 Operations identified as having significant risk for incidents of child labor, and measures taken to contribute to the elimination of child labor. 1, 5
ASPECT: FORCED AND COMPULSORY LABOR
GRI Guideline Corresponding Pfizer Material UNGC Principle HR7 Operations identified as having significant risk for incidents of forced or compulsory labor, and measures to contribute to the elimination of forced or compulsory labor. 1, 4
ASPECT: SECURITY PRACTICES
GRI Guideline Corresponding Pfizer Material UNGC Principle HR8 Percentage of security personnel trained in the organization's policies or procedures concerning aspects of human rights that are relevant to operations. 1, 2
ASPECT: INDIGENOUS RIGHTS
GRI Guideline Corresponding Pfizer Material UNGC Principle HR9 Total number of incidents of violations involving rights of indigenous people and actions taken. 1
Covered
Partially Covered
Not Covered
-
SocietySociety Performance Indicators focus attention on the impacts organizations have on the communities in which they operate, and disclosing how the risks that may arise from interactions with other social institutions are managed and mediated. In particular, information is sought on the risks associated with bribery and corruption, undue impudence in public policy-making, and monopoly practices.
- Disclosure on Management Approach (Society)
Provide a concise disclosure on the following Management Approach items with reference to the Society Aspects:
- Community;
- Corruption;
- Public Policy;
- Anti-Competitive Behavior; and
- Compliance.
GRI Guideline Corresponding Pfizer Material UNGC Principle GOALS AND PERFORMANCE
Organization-wide goals regarding performance relevant to the Aspects indicated above.
Use organization-specific Indicators as needed in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.Ethics POLICY
Brief, organization-wide policy (or policies) that defines the organization's overall commitment relating to the Society Aspects or state where this can be found in the public domain (e.g., web link).Ethics ORGANIZATIONAL RESPONSIBILITY
The most senior position with operational responsibility for Society Aspects or explain how operational responsibility is divided at the senior level for these Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.Corporate Compliance TRAINING AND AWARENESS
Procedures related to training and raising awareness in relation to the Society Aspects.MONITORING AND FOLLOW-UP
Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain.
List of certifications for performance or certifications systems, or other approaches to auditing/verifying the reporting organization or its supply chain.Colleagues
PSCI and External Certifications
EHS External Supply: Commitments and Actions
ComplianceADDITIONAL CONTEXTUAL INFORMATION
Additional relevant information required to understand organizational performance, such as:
- Key successes and shortcomings;
- Major organizational risks and opportunities;
- Major changes in the reporting period to systems or structures to improve performance; and
- Key strategies for implementing policies or achieving performance.
Ethics
Covered
Partially Covered
Not Covered
- Society Performance Indicators
ASPECT: COMMUNITY
GRI Guideline Corresponding Pfizer Material UNGC Principle SO1 Nature, scope, and effectiveness of any programs and practices that assess and manage the impacts of operations on communities, including entering, operating, and exiting. 1
ASPECT: CORRUPTION
GRI Guideline Corresponding Pfizer Material UNGC Principle SO2 Percentage and total number of business units analyzed for risks related to corruption. 10 SO3 Percentage of employees trained in organization's anti-corruption policies and procedures. 10 SO4 Actions taken in response to incidents of corruption. 10
ASPECT: PUBLIC POLICY
GRI Guideline Corresponding Pfizer Material UNGC Principle SO5 Public policy positions and participation in public policy development and lobbying. Ethics 10 SO6 Total value of financial and in-kind contributions to political parties, politicians, and related institutions by country. Ethics 10
ASPECT: ANTI-COMPETITIVE BEHAVIOR
GRI Guideline Corresponding Pfizer Material UNGC Principle SO7 Total number of legal actions for anti-competitive behavior, anti-trust, and monopoly practices and their outcomes.
ASPECT: COMPLIANCE
GRI Guideline Corresponding Pfizer Material UNGC Principle SO8 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with laws and regulations.
Covered
Partially Covered
Not Covered
-
Product ResponsibilityProduct Responsibility Performance Indicators address the aspects of a reporting organization's products and services that directly abet customers, namely, health and safety, information and labeling, marketing, and privacy.
These aspects are chiefly covered through disclosure on internal procedures and the extent to which these procedures are not complied with.
- Disclosure on Management Approach (Product Responsibility)
Provide a concise disclosure on the following Management Approach items with reference to the Product Responsibility Aspects:
- Customer Health and Safety;
- Product and Service Labeling;
- Marketing Communications;
- Customer Privacy; and
- Compliance.
GRI Guideline Corresponding Pfizer Material UNGC Principle GOALS AND PERFORMANCE
Organization-wide goals regarding performance relevant to the Product Responsibility Aspects.
Use organization-specific Indicators (as needed) in addition to the GRI Performance Indicators to demonstrate the results of performance against goals.Patient Safety
Research & Development
Ethics
Sales and Marketing CompliancePOLICY
Brief, organization-wide policy (or policies) that defines the organization's overall commitment to the Product Responsibility Aspects, or state where this can be found in the public domain (e.g., web link).Patient Safety
Research & Development
Ethics
Sales and Marketing ComplianceORGANIZATIONAL RESPONSIBILITY
The most senior position with operational responsibility for Product Responsibility Aspects, or explain how operational responsibility is divided at the senior level for Product Responsibility Aspects. This differs from Disclosure 4.1, which focuses on structures at the governance level.TRAINING AND AWARENESS
Procedures related to training and raising awareness in relation to the Product Responsibility Aspects.MONITORING AND FOLLOW-UP
Procedures related to monitoring and corrective and preventive actions, including those related to the supply chain.
List of certifications for product responsibility-related performance or certification systems, or other approaches to auditing/verifying the reporting organization or its supply chain.Colleagues
ComplianceADDITIONAL CONTEXTUAL INFORMATION
Additional relevant information required to understand organizational performance, such as:
- Key successes and shortcomings;
- Major organizational risks and opportunities;
- Major changes in the reporting period to systems or structures to improve performance; and
- Key strategies for implementing policies or achieving performance.
Patient Safety
Research & Development
Ethics
Sales and Marketing Compliance
Covered
Partially Covered
Not Covered
- Product Responsibility Performance Indicators
ASPECT: CUSTOMER HEALTH AND SAFETY
GRI Guideline Corresponding Pfizer Material UNGC Principle PR1 Life cycle stages in which health and safety impacts of products and services are assessed for improvement, and percentage of significant products and services categories subject to such procedures. Environment
Research & Development
Patient SafetyPR2 Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomes.
ASPECT: PRODUCT AND SERVICE LABELING
GRI Guideline Corresponding Pfizer Material UNGC Principle PR3 Type of product and service information required by procedures, and percentage of significant products and services subject to such information requirements. Product Labeling PR4 Total number of incidents of non-compliance with regulations and voluntary codes concerning product and service information and labeling, by type of outcomes. PR5 Practices related to customer satisfaction, including results of surveys measuring customer satisfaction.
ASPECT: MARKETING COMMUNICATIONS
GRI Guideline Corresponding Pfizer Material UNGC Principle PR6 Programs for adherence to laws, standards, and voluntary codes related to marketing communications, including advertising, promotion, and sponsorship. Ethics
Compliance10 PR7 Total number of incidents of non-compliance with regulations and voluntary codes concerning marketing communications, including advertising, promotion, and sponsorship by type of outcomes.
ASPECT: CUSTOMER PRIVACY
GRI Guideline Corresponding Pfizer Material UNGC Principle PR8 Total number of substantiated complaints regarding breaches of customer privacy and losses of customer data.
ASPECT: COMPLIANCE
GRI Guideline Corresponding Pfizer Material UNGC Principle PR9 Monetary value of significant fines for non-compliance with laws and regulations concerning the provision and use of products and services.
Covered
Partially Covered
Not Covered